Saturday 17 October 2026 Export MIST’s income statement to Excel — free account

Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 million, up 54.6% from fiscal 2023. In the quarter to June 2026, revenue fell 62.7%, EPS fell 5.00%, free cash flow fell 80.8% and total debt rose 7.19%, each against the same quarter a year earlier.

0.71 0.09 −11.25%

Follow MIST

Alert me

Market cap: $98.9M
P/E: 0.0×
Fwd P/E: −1.3×
Dividend yield: —
F-score: n/a
Altman Z: −4.65
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(35,522.62%)	(456.88%)	(229.65%)	(260.65%)	+8 more TTM periods Free account
ROA Full definition →	(73.36%)	(53.49%)	(66.71%)	(68.07%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(52.97%)	(39.79%)	(64.05%)	(76.05%)
Average Days of Receivables Full definition →	237.45	177.29	0.00	0.00
Free Cash Flow per Share Full definition →	(0.44)	(0.40)	(0.59)	(0.45)
Free Cash Flow Full definition →	(61.65)	(51.48)	(49.34)	(43.15)
Capital Expenditures Full definition →	(0.36)	(0.34)	(0.30)	(0.04)
Other line items
Cash ROIC Full definition →	(24.85%)	(18.49%)	(24.08%)	(27.09%)
Accounts Receivable Turnover Full definition →	2.42	2.97	0.00	0.00
Accounts Payable Turnover Full definition →	0.01	0.01	0.00	0.00
Inventory Turnover Full definition →	0.00	0.00	—	—
Average Days of Payables Full definition →	32,826.70	45,729.94	0.00	0.00
Days of Inventory on Hand Full definition →	18,335.43	8,331.13	0.00	—
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	306.23%	262.60%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	579.89%	271.42%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	140.12%	118.50%	0.00%	0.00%
Interest Coverage Full definition →	(7.25)	(9.28)	(16.19)	(15.17)
Operating CF/Net income Full definition →	0.73	0.75	0.78	0.74
Depreciation/Fixed assets Full definition →	0.37	0.29	0.22	0.78
Capex/Depreciation Full definition →	(2.07)	(2.38)	(2.65)	(0.39)
Revenue per Share Full definition →	0.04	0.05	0.00	0.00
Operating CF per Share Full definition →	(0.44)	(0.39)	(0.58)	(0.45)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.07	0.05	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly